Patent · US Active

Reduced size self-delivering RNAi compounds

US10240149B2 · kind B2 · utility

19Cited by
206References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 2, 2015
Grant dateMar 26, 2019
Priority date—
Expiry dateJun 2, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/51
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to methods for in vivo administration of sd-rxRNA molecules.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.